Skip to content
Toggle navigation
Home
About ALS
Toggle menu
What is ALS?
Causes and risk factors
Diagnosis
Symptoms
Speech problems
Breathing and swallowing
Pseudobulbar affect
Types of ALS
Familial ALS
Sporadic ALS
Living with ALS
Mental health
Diet
Exercise
Aids and adaptations
Treatments
Toggle menu
Approved treatments
Experimental treatments
Non-drug treatments
News
Columns
Toggle menu
Joyful Sorrow
— Kristin Neva
Living Well With ALS
— Dagmar Munn
OutSpoken
— James Clingman
Thunder Road
— Juliet Taylor
Archived columns
The Mighty Mind
— Rachel Doboga
In memoriam
Notes From the ALS Front
— Rick Jobus
ALS roadmap
Toggle menu
Multifaceted ALS treatment strategy
ALS facts vs. fiction
Early ALS intervention
Navigating complex treatment plans
Insurance and finances
Next steps after ALS diagnosis
ALS stages and progression
Forums
Advocacy partners
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Search for:
Search
ad system banner
[adrotate group=”1″]
Print This Page
Recent Posts
Avextra to launch Phase 2 trial of cannabis-based medicine in Italy
Good memories sustain us when life with ALS is hard
Highly targeted approach supports ALS gene therapy development
Neuvivo requests FDA approval of ALS treatment NP001
FGF4 shows benefits in ALS but fails to protect motor neurons
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Your Email
Subscribe
Leave this field empty if you're human:
We use cookies
to enhance your experience on our website.
Privacy Policy
Accept
